Skip to main content

Table 2 The association between prevalent genotypes of human papilloma virus persistent positivity and cervical cancer clinical pathological data

From: The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China

HPV persistent infection
Data No.
1108
HPV
+
χ 2 P Multiple
HPV(+)
χ 2 P HPV
16+
χ 2 P HPV
58+
χ 2 P HPV
18+
χ 2 P HPV
52+
χ 2 P HPV
33+
χ 2 P
Age                       
<35 376 326 0.903 0.380 53 5.048 0.025 69 3.013 0.097 18 6.004 0.016 21 0.140 0.789 14 0.658 0.446 6 7.518 0.005
≥35 732 649    143    105    65    45    35    36   
FIGO stage                       
Ia~Ib 643 562 0.511 0.513 115 0.040 0.873 91 2.786 0.112 55 2.497 0.133 38 0.006 1.000 28 0.017 0.884 26 0.269 0.636
IIa~IV 465 413    81    83    28    28    21    16   
Grade 1069                      
G1 ~ G2 531 479 1.314 0.28 109 3.387 0.069 81 0.810 0.407 40 0.003 1.000 30 0.501 0.526 25 0.037 0.884 22 0.472 0.523
G3 538 496    87    93    41    36    24    18   
Lymph metastasis 1043                      
no 739 692 0.800 0.417 135 0.094 0.792 113 3.533 0.068 54 1.077 0.312 36 9.074 0.005 34 0.000 1.000 27 0.914 0.386
yes 304 280    58    61    28    30    14    15   
Histology                       
Squamous
carcinoma
767 681 1.477 0.230 129 1.298 0.268 121 0.010 1.000 57 0.013 0.902 38 4.469 0.039 35 0.117 0.874 28 0.134 0.734
Adeno-
carcinoma
341 294    67    53    26    28    14    14